BASI Financial Facts

Research and development: 157K
Cost of service revenue: 3.34M
See Full Income Statement

Accounts payable: 2.46M
Total liabilities and shareholders' equity: 21.78M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 8/15/16 *Est. EPS Growth Rate -200.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate -6.8% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/12/16 Q216 -$0.03N/A N/A $5.34M$5.73M N/A Details
2/16/16 Q116 -$0.06N/A N/A $4.9M$5.95M N/A Details
12/17/15 Q415 -$0.09N/A N/A $4.98M$6.42M N/A Details
8/13/15 Q315 $0.16N/A N/A $6.15M$6.03M N/A Details
5/14/15 Q215 -$0.01N/A N/A $5.73M$5.92M N/A Details
2/12/15 Q115 $0.01N/A N/A $5.85M$6.22M N/A Details
12/22/14 Q414 -$0.02N/A N/A $6.42M$5.51M N/A Details
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details